BOLTON SECURITIES CORPORATION’s Virtus Biotech ETF BBP Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26.2K	Buy	+315	New	+$25.9K	﹤0.01%	1384

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millington Securities Red Bank, New Jersey $362M AUM

WBI Investments Red Bank, New Jersey $384M AUM 34.15% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's BBP Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Virtus Biotech ETF (BBP) in Q1 2026: 315 shares worth $26.2K. The stake represents ﹤0.01% of the portfolio and ranks #1384 among its holdings.

27 funds tracked by Wall St. Rank hold BBP as of Q1 2026.

BOLTON SECURITIES CORPORATION held 315 shares of Virtus Biotech ETF worth $26.2K as of Q1 2026.
Virtus Biotech ETF was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
Virtus Biotech ETF made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1384 holding.
27 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.